Shitang Ma

672 total citations
53 papers, 537 citations indexed

About

Shitang Ma is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Shitang Ma has authored 53 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Pharmacology and 9 papers in Organic Chemistry. Recurrent topics in Shitang Ma's work include Pharmacological Effects of Natural Compounds (11 papers), Traditional Chinese Medicine Analysis (9 papers) and Ginseng Biological Effects and Applications (7 papers). Shitang Ma is often cited by papers focused on Pharmacological Effects of Natural Compounds (11 papers), Traditional Chinese Medicine Analysis (9 papers) and Ginseng Biological Effects and Applications (7 papers). Shitang Ma collaborates with scholars based in China, Thailand and Japan. Shitang Ma's co-authors include Cheng‐Tao Feng, Jun Zhao, Ge Hong, Guoliang Dai, Zhong Li, Zaigang Luo, Liang Feng, Mingyu Li, Wei Tan and Xinzhong Hao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Communications and The Journal of Organic Chemistry.

In The Last Decade

Shitang Ma

51 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shitang Ma China 14 206 106 77 73 61 53 537
Avantika Barve United States 11 398 1.9× 78 0.7× 63 0.8× 78 1.1× 58 1.0× 24 748
Guanzhong Wu China 10 368 1.8× 88 0.8× 31 0.4× 85 1.2× 56 0.9× 24 745
Nu Ry Song South Korea 14 304 1.5× 42 0.4× 62 0.8× 106 1.5× 42 0.7× 15 586
Ximena Paredes‐Gonzalez United States 8 507 2.5× 72 0.7× 57 0.7× 55 0.8× 63 1.0× 9 751
Srishti Mishra Singapore 12 392 1.9× 147 1.4× 71 0.9× 78 1.1× 151 2.5× 14 780
Reza Entezari Heravi Iran 7 192 0.9× 49 0.5× 56 0.7× 34 0.5× 59 1.0× 11 567
Miaomiao Liu China 13 244 1.2× 32 0.3× 57 0.7× 98 1.3× 52 0.9× 30 597
Catherine A. Cordova United States 8 190 0.9× 44 0.4× 39 0.5× 70 1.0× 33 0.5× 10 500
Sharon Varghese Qatar 6 405 2.0× 66 0.6× 100 1.3× 50 0.7× 103 1.7× 7 806
Ayako Tomizawa Japan 11 330 1.6× 48 0.5× 65 0.8× 89 1.2× 102 1.7× 19 620

Countries citing papers authored by Shitang Ma

Since Specialization
Citations

This map shows the geographic impact of Shitang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shitang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shitang Ma more than expected).

Fields of papers citing papers by Shitang Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shitang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shitang Ma. The network helps show where Shitang Ma may publish in the future.

Co-authorship network of co-authors of Shitang Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Shitang Ma. A scholar is included among the top collaborators of Shitang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shitang Ma. Shitang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shang, H.M., et al.. (2025). Preparation and biomedical application of light-responsive hydrogels based on natural products. Frontiers in Pharmacology. 16. 1714907–1714907.
2.
Ma, Shitang, et al.. (2025). From basic to clinical translation: advances and perspectives of photodynamic nanodrugs. Frontiers in Pharmacology. 16. 1606372–1606372. 2 indexed citations
3.
Li, Zhenxin, et al.. (2024). A green and efficient monoacylation strategy for symmetrical diamines in microreactors. Reaction Chemistry & Engineering. 9(9). 2411–2418. 1 indexed citations
4.
Ma, Xueying, et al.. (2024). IRF2 Affects LPS- and IFN-γ-Induced Pro-Inflammatory Responses, Cell Viability, Migration and Apoptosis of Macrophages by Regulating IRG1. Journal of Inflammation Research. Volume 17. 9651–9664. 2 indexed citations
5.
Qi, Xiang, Yuan Gao, Bing Xu, et al.. (2023). Design, synthesis and anti-tumor efficacy evaluation of novel 1,3-diaryl propane-based polyphenols obtained from Claisen rearrangement reaction. Bioorganic Chemistry. 140. 106753–106753. 2 indexed citations
6.
7.
Ma, Shitang, Ning Zhang, Shijuan Liu, et al.. (2022). Synthesis and Discovery of Ligustrazine–Heterocycle Derivatives as Antitumor Agents. Frontiers in Chemistry. 10. 941367–941367. 2 indexed citations
8.
Zhang, Ning, Jiawen Wang, Shuo Huang, et al.. (2021). Emodin Inhibits the Proliferation of MCF-7 Human Breast Cancer Cells Through Activation of Aryl Hydrocarbon Receptor (AhR). Frontiers in Pharmacology. 11. 622046–622046. 37 indexed citations
9.
Hong, Ge, Hao Wu, Shitang Ma, & Zhe Su. (2020). Catechins from oolong tea improve uterine defects by inhibiting STAT3 signaling in polycystic ovary syndrome mice. Chinese Medicine. 15(1). 125–125. 24 indexed citations
10.
Y, Li, et al.. (2019). Isobavachalcone isolated from Psoralea corylifolia inhibits cell proliferation and induces apoptosis via inhibiting the AKT/GSK-3β/β-catenin pathway in colorectal cancer cells. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Ma, Shitang, et al.. (2019). MiR-9 promotes the phenotypic switch of vascular smooth muscle cells by targeting KLF5. TURKISH JOURNAL OF MEDICAL SCIENCES. 49(3). 928–938. 13 indexed citations
12.
Gao, Xuan, et al.. (2019). [Mechanism of Gardenia jasminoides against cholestasis based on network pharmacology].. PubMed. 44(13). 2709–2718. 4 indexed citations
13.
Li, Yuanyuan, Heng Chen, Kang Shao, et al.. (2018). Coptisine suppresses tumor growth and progression by down-regulating MFG-E8 in colorectal cancer. RSC Advances. 8(54). 30937–30945. 23 indexed citations
14.
Song, Jie, Xiao‐Bin Jia, Mingyu Li, et al.. (2018). Distinctive Roles of Sirtuins on Diabetes, Protective or Detrimental?. Frontiers in Endocrinology. 9. 724–724. 49 indexed citations
15.
Ma, Shitang, et al.. (2018). The Herb‐Drug Interaction of Clopidogrel and Xuesaitong Dispersible Tablet by Modulation of the Pharmacodynamics and Liver Carboxylesterase 1A Metabolism. Evidence-based Complementary and Alternative Medicine. 2018(1). 5651989–5651989. 10 indexed citations
16.
17.
Ma, Shitang, Cheng‐Tao Feng, Guoliang Dai, et al.. (2015). In silico target fishing for the potential bioactive components contained in Huanglian Jiedu Tang (HLJDD) and elucidating molecular mechanisms for the treatment of sepsis. Chinese Journal of Natural Medicines. 13(1). 30–40. 13 indexed citations
18.
Ma, Shitang, et al.. (2014). Synergistic Effects of Clopidogrel and Fufang Danshen Dripping Pills by Modulation of the Metabolism Target and Pharmacokinetics. Evidence-based Complementary and Alternative Medicine. 2014(1). 789142–789142. 7 indexed citations
19.
Ma, Shitang, Cheng‐Tao Feng, Xiaolin Zhang, et al.. (2013). The multi-target capabilities of the compounds in a TCM used to treat sepsis and their in silico pharmacology. Complementary Therapies in Medicine. 21(1). 35–41. 20 indexed citations
20.
Ma, Shitang, et al.. (2010). Uncoupling Protein 2 Ablation Exacerbates High-Salt Intake-Induced Vascular Dysfunction. American Journal of Hypertension. 23(8). 822–828. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Avantika Barve Breakdown of academic impact, for papers by Guanzhong Wu Breakdown of academic impact, for papers by Nu Ry Song Breakdown of academic impact, for papers by Ximena Paredes‐Gonzalez Breakdown of academic impact, for papers by Srishti Mishra Breakdown of academic impact, for papers by Reza Entezari Heravi Breakdown of academic impact, for papers by Miaomiao Liu Breakdown of academic impact, for papers by Catherine A. Cordova Breakdown of academic impact, for papers by Sharon Varghese Breakdown of academic impact, for papers by Ayako Tomizawa
Rankless by CCL
2026